信铭生命科技(00474)：14.76亿股代价股份经已配发及发行予IFGL的代名人

智通财经03-03

智通财经APP讯，信铭生命科技(00474)发布公告，认购协议所载的所有条件已于2026年3月3日获达成，而完成已于2026年3月3日根据认购协议的条款及条件作实。

完成后，IFGL将不会成为本公司的附属公司，而将作为本公司以公平值计量且其变化计入其他全面收益的金融资产入账。

完成后，14.76亿股代价股份经已配发及发行予IFGL的代名人。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2616341771?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-03 19:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616341771","market":"us","top_or_hot":-1,"title":"信铭生命科技(00474)：14.76亿股代价股份经已配发及发行予IFGL的代名人","media":"智通财经","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/00474\">信铭生命科技</a>(00474)发布公告，认购协议所载的所有条件已于2026年3月3日获达成，而完成已于2026年3月3日根据认购协议的条款及条件作实。</p><p>完成后，IFGL将不会成为本公司的附属公司，而将作为本公司以公平值计量且其变化计入其他全面收益的金融资产入账。</p><p>完成后，14.76亿股代价股份经已配发及发行予IFGL的代名人。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>信铭生命科技(00474)：14.76亿股代价股份经已配发及发行予IFGL的代名人</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n信铭生命科技(00474)：14.76亿股代价股份经已配发及发行予IFGL的代名人\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经</strong><span class=\"h-time small\">2026-03-03 19:37</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/00474\">信铭生命科技</a>(00474)发布公告，认购协议所载的所有条件已于2026年3月3日获达成，而完成已于2026年3月3日根据认购协议的条款及条件作实。</p><p>完成后，IFGL将不会成为本公司的附属公司，而将作为本公司以公平值计量且其变化计入其他全面收益的金融资产入账。</p><p>完成后，14.76亿股代价股份经已配发及发行予IFGL的代名人。</p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.zhitongcaijing.com/content/detail/1409609.html\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00474","symbol_name":"信铭生命科技","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1409609.html","article_id":"2616341771","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616341771","pubTimestamp":1772537825,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，信铭生命科技(00474)发布公告，认购协议所载的所有条件已于2026年3月3日获达成，而完成已于2026年3月3日根据认购协议的条款及条件作实。完成后，IFGL将不会成为本公司的附属公司，而将作为本公司以公平值计量且其变化计入其他全面收益的金融资产入账。完成后，14.76亿股代价股份经已配发及发行予IFGL的代名人。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"00474":"信铭生命科技","IFGL":"国际发达市场房地产ETF-iShares","BK1188":"消费信贷"},"translate_title":"Xinming Life Sciences (00474): 1.476 billion consideration shares have been allotted and issued to IFGL nominees","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IFGL":1.5,"00474":1.5},"content_text":"智通财经APP讯，信铭生命科技(00474)发布公告，认购协议所载的所有条件已于2026年3月3日获达成，而完成已于2026年3月3日根据认购协议的条款及条件作实。完成后，IFGL将不会成为本公司的附属公司，而将作为本公司以公平值计量且其变化计入其他全面收益的金融资产入账。完成后，14.76亿股代价股份经已配发及发行予IFGL的代名人。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616341771","isCrawlerRequest":true}